Financial statements Drogomex
Balance sheet data of DROGOMEX
|
Year
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|
| Total assets | 46 480 822,10 | 61 157 442,88 | 60 290 316,44 | 77 839 039,10 |
| A. Fixed assets | 1 793 589,65 | 3 712 312,85 | 5 099 258,93 | 5 372 537,75 |
| B. Current assets | 44 687 232,45 | 57 445 130,03 | 55 191 057,51 | 72 466 501,35 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 46 480 822,10 | 61 157 442,88 | 60 290 316,44 | 77 839 039,10 |
| A. Equity | 11 167 613,07 | 10 220 757,49 | 13 807 963,48 | 23 202 376,52 |
| B. Liabilities and provisions for liabilities | 35 313 209,03 | 50 936 685,39 | 46 482 352,96 | 54 636 662,58 |
| I. Long-term liabilities | 255 471,00 | 127 735,50 | 0,00 | 252 969,36 |
| II. Short-term liabilities | 26 537 091,03 | 38 999 490,89 | 36 854 269,96 | 42 213 601,22 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.